Effective maintenance treatment of reflux esophagitis with low-dose lansoprazole: A randomized, double-blind, placebo-controlled trial

Annals of Internal Medicine

Volumn 124, Issue 10, 1996, Pages 859-867

  Robinson, Malcolm ^a   Lanza, Frank ^b   Avner, Dennis ^c   Haber, Marian ^d  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c Hahnemann University ^*  (United States)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATTAPULGITE; LANSOPRAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PROTON PUMP INHIBITOR; RANITIDINE;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ESOPHAGOSCOPY; FEMALE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REFLUX ESOPHAGITIS; STOMACH BIOPSY;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; AGED, 80 AND OVER; DOUBLE-BLIND METHOD; ESOPHAGITIS, PEPTIC; ESOPHAGOSCOPY; FEMALE; FOLLOW-UP STUDIES; GASTRIC ACID; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PLACEBOS; PROTON PUMPS; RECURRENCE; SECRETORY RATE;

EID: 0029931639     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-124-10-199605150-00001     Document Type: Article

References (22)

1. DeVault KR, Castell DO. Current diagnosis and treatment of gastroesophageal reflux disease Mayo Clin Proc 1994,69.867-76
2. Tytgat GM, Nio CY, Schotborgh RH. Reflux esophagitis Scand J Gastroenterol Suppl 1990,25 1-12
3. Toussaint J, Gossuin A, Deruyttere M, Huble F, Devis G. Healing and prevention of relapse of reflux oesophagitis by cisapride, Gut. 1991,32: 1280-5.
4. Koelz HR, Birchler R, Bretholz A, Bron B, Capitaine Y, Delmore G, et al. Healing and relapse of reflux esophagitis during treatment with ranitidine Gastroenterology 1986,91 1198-205
5. 2-receptor antagonist prophylaxis does not prevent relapse of reflux esophagitis [Abstract] Gut 1989,30:1494
6. Tytgat GN, Anker Hansen OJ, Carling L, deGroot GH, Geldof H, Glise H, et at. Effect of cisapride on relapse of reflux oesophagitis, healed with an antisecretory drug Scand J Gastroenterol 1992;27.175-83
7. Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy JH, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole Gastroenterology. 1988,95 903-12
8. Hetzel DJ. Controlled clinical trials of omeprazole in the long-term management of reflux disease. Digestion 1992,5(Suppl 1).35-42
9. Laursen LS, Bondesen S, Hansen J, Sanchez G, Sebelin E, Havelund T, et al. Omeprazole 10 mg or 20 mg daily for the prevention of relapse in gastroesophageal reflux disease? A double-blind comparative study [Abstract] Gastroenterology 1992,102 A109
10. Berlin R, Ebel D, Cook T. Famotidine (F) 20 HS & 40 HS vs placebo (P) in the maintenance therapy (MT) of reflux esophagitis (RE) Results of a doubleblind, multicenter trial [Abstract] Gastroenterology 1989,96:A39.
11. Kaul B, Petersen H, Erichsen H, Myrvold HE, Grette K, Halvorsen T, et al. Gastroesophageal reflux disease Acute and maintenance treatments with cimetidme Scand J Gastroenterol 1986;21 139-45.
12. Barradell LB, Faulds D, McTavish D. Lansoprazole A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders. Drugs 1992,44.225-50
13. Hatlebakk JG, Berstad A, Carling L, Svedberg LE, Unge P, Ekstrom P, et al. Lansoprazole versus omeprazole in short-term treatment of reflux oesophagitis Results of a Scandinavian multicentre trial Scand J Gastroenterol 1993;28 224-8.
14. Robinson M, Sahba B, Avner D, Jhala N, Greski-Rose PA, Jennings DE. A comparison of lansoprazole and ranitidine in the treatment of erosive oesophagitis. Multicentre Investigational Group. Aliment Pharmacol Ther 1996, 9 25-31.
15. Solcia E, Bordi C, Creutzfeldt W, Dayal Y, Dayan AD, Falkmer S, et al. Histopathological classification of nonantral gastric endocrine growths in man. Digestion. 1988,41.185-200
16. Koch G, McCanless I, Ward JF Jr. Interpretation of statistical methodology associated with maintenance trials Am J Med 1984;77(5B):43-50.
17. Bardhan KD, Long R, Hawkey CJ, Wormsley KG, Brocklebank D, Moules I, et al. Lansoprazole, a new proton-pump inhibitor, vs ranitidine in the treatment of reflux erosive esophagitis [Abstract] Gastroenterology 1991,100 A30
18. Benhaim MC, Evreux M, Salducci J, Petite JP, Lemaire M. Lansoprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trial [Abstract] Gastroenterology 1990,98 A20.
19. 2-blocker-resistant esophagitis Dig Dis Sci 1991,36 552-7
20. Jansen JB, Klinkenberg-Knol EC, Meuwisesen SG, DeBruijne JW, Festen HP, Snel P, et al. Effect of long-term treatment with omeprazole on serum gastrin and serum group A and C pepsinogens in patients with reflux esophagitis Gastroenterology 1990, 99 621-8
21. Lamberts R, Creutzfeldt W, Stockmann F, Jacubaschke U, Maas S, Brunner G. Long-term omeprazole treatment in man effects on gastric endocrine cell populations Digestion 1988;39 126-35
22. Solcia E, Fiocca R, Havu N, Dalvag A, Carlsson R. Gastric endocrine cells and gastritis in patients receiving long-term omeprazole treatment. Digestion. 1992;5(Suppl 1) 82-92.